Schedule 13D ownership disclosure
Biotie Therapies Corp.
Security class unavailable
Event date: 2016-05-02
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 97.4000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-16-575576
- Form type
- SC 13D
- Filer
- Acorda Therapeutics, Inc.
- CIK
- CIK 1008848
- Filed
- May 04, 2016
- Reporting period
- May 02, 2016
- Description
- Schedule 13D beneficial ownership